Latest news on Alzheimer's
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
The BBRC hosts a European symposium on the latest technologies in biomarkers
The participants of the conference were able to see first-hand the center's new Fluid Biomarkers and Translational Neurology laboratory.
Dr. Marta del Campo, appointed Director of the BBRC Fluid Biomarkers Platform
La investigadora tindrà la responsabilitat de desenvolupar, validar i implementar biomarcadors en sang per a la detecció precoç de l’Alzheimer.
Dr. Marc Suárez-Calvet receives the "2021 Alzheimer Award" from the SEN
The award recognizes the leadership, work and key contributions in the field of biochemical biomarkers of the researcher.
Dr. Eider Arenaza-Urquijo talks about brain resilience at the Science Festival
The BBRC researcher has offered a micro-lecture on how lifestyle habits and mental health affect the brain's ability to prevent neurodegenerative diseases.
Outstanding participation of the BBRC in the XVIII Spanish Biometrics Conference
At this conference, dedicated to scientific techniques for measuring the parameters of living beings, researchers from the Neurobiogenetics team presented three talks and a poster.
A CNIC project in collaboration with the BBRC receives an Alzheimer's Disease Research Standard Award from the BrightFocus Foundation
The project focuses on the longitudinal determination of plasma biomarkers of neuronal damage, neuroinflammation and Alzheimer's disease.
The BBRC, participating center in a new clinical trial
The international study Skyline plans to enroll 1.200 participants worldwide to assess a new treatment against Alzheimer's disease.
The researcher Marta Milà defends the third doctoral thesis done at the BBRC
The thesis develved into urrent knowledge of the disease during its preclinical stage and provides new evidence for its early detection.
Dr. Eider Arenaza-Urquijo, named ISGlobal Associated Researcher
Currently, the BBRC researcher collaborates with ISGlobal in the NCDs (Non-Communicable Diseases) and Environment program on the effects of the pandemic on mental health.
